ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial ', The Lancet. Respiratory Medicine, vol. 10, no. 10, pp. 972-984 . https://doi.org/10.1016/S2213-2600(22)00215-6